Related references
Note: Only part of the references are listed.Tc-99m-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent
TG Stopar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo
J Hoffend et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Imaging of central nervous system lymphomas with iodine-123 labeled rituximab
M Dietlein et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Conjugation of DOTA using isolated phenolic active esters: The labeling and biodistribution of albumin as blood pool marker
W Mier et al.
BIOCONJUGATE CHEMISTRY (2005)
177Lu-DOTA-lanreotide:: A novel tracer as a targeted agent for tumor therapy
S Banerjee et al.
NUCLEAR MEDICINE AND BIOLOGY (2004)
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
PM Smith-Jones et al.
NATURE BIOTECHNOLOGY (2004)
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N,N′-tetraacetic acid for radiolabeling proteins
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2:: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells
CJ Smith et al.
NUCLEAR MEDICINE AND BIOLOGY (2003)
Design and synthesis of 225Ac radioimmunopharmaceuticals
MR McDevitt et al.
APPLIED RADIATION AND ISOTOPES (2002)
Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapy
U Pandey et al.
APPLIED RADIATION AND ISOTOPES (2002)
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
Ö Ugur et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)